Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2015 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24.
Lancet. 2023.
PMID: 37499670
Clinical Trial.
[TG13: THE UPDATED TOKYO'S CLINICAL RECOMMENDATIONS FOR TREATMENT OF AN ACUTE CHOLANGITIS AND CHOLECYSTITIS].
Usenko AY, Yareshko VG, Nichitaylo ME, Mikheyev YA, Andreyeshchev SA.
Usenko AY, et al. Among authors: yareshko vg.
Klin Khir. 2015 Oct;(10):5-10.
Klin Khir. 2015.
PMID: 26946649
Review.
Russian.
Item in Clipboard
Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial.
Dunbar LM, Milata J, McClure T, Wasilewski MM; SIMPLIFI Study Team.
Dunbar LM, et al.
Antimicrob Agents Chemother. 2011 Jul;55(7):3476-84. doi: 10.1128/AAC.00029-11. Epub 2011 May 2.
Antimicrob Agents Chemother. 2011.
PMID: 21537018
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite